Clinical Features of Families with a Novel Pathogenic Mutation in Sepiapterin Reductase
Feda E. Mohamed(United Arab Emirates University), Fatma Al‐Jasmi(United Arab Emirates University), Praseetha Kizhakkedath(Institut thématique Génétique, génomique et bioinformatique), Lara Alzyoud(Al Ain University), Mohammad A. Ghattas(Al Ain University), Matthew J. Farrer(University of Florida), Mohammed Tabouni(United Arab Emirates University), Ibrahim Baydoun(École Normale Supérieure Paris-Saclay), Qudsia Shaukat(Tawam Hospital), Rim Amouri(Tunis University), Samia Ben Sassi(Institut National de Santé Publique), Hiba Alblooshi(United Arab Emirates University), André Fienemann(University of Lübeck), Joanne Trinh(University of Lübeck)
Cited by 0
Related Papers
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
|Nature Genetics|2011|635
Comprehensive Research Synopsis and Systematic Meta-Analyses in Parkinson's Disease Genetics: The PDGene Database
|PLoS Genetics|2012|543
A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1
|Nature Medicine|1998|349
Genomic investigation of α‐synuclein multiplication and parkinsonism
|Annals of Neurology|2008|340